Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience.

Aquino CC, Felício AC, Castro PC, Oliveira RA, Silva SM, Borges V, Ferraz HB.

Arq Neuropsiquiatr. 2012 Sep;70(9):662-6.

2.

[Blepharospasm: treatment with botulinum toxin].

Barbosa ER, Silva HC, Haddad MS, Bittar MS.

Rev Hosp Clin Fac Med Sao Paulo. 1996 Nov-Dec;51(6):220-3. Portuguese.

PMID:
9239894
3.

[Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].

Schnider P, Voller B, Moraru K, Auff E.

Wien Klin Wochenschr. 1999 Oct 29;111(20):825-9. Review. German. No abstract available.

PMID:
10586486
4.

Dystonic frowning without blepharospasm.

Hirota N, Hirota M, Mezaki T.

Parkinsonism Relat Disord. 2008 Nov;14(7):579-80. doi: 10.1016/j.parkreldis.2007.12.001. Epub 2008 Mar 3.

PMID:
18316230
5.
6.

[Botulinum toxin A: experience in the treatment of 115 patients].

Andrade LA, Borges V, Ferraz HB, Azevedo-Silva SM.

Arq Neuropsiquiatr. 1997 Sep;55(3B):553-7. Portuguese.

PMID:
9629404
7.

Botulinum toxin in movement disorders.

Papapetropoulos S, Singer C.

Semin Neurol. 2007 Apr;27(2):183-94. Review.

PMID:
17390263
8.

Craniocervical dystonia: clinical and pathophysiological features.

Colosimo C, Suppa A, Fabbrini G, Bologna M, Berardelli A.

Eur J Neurol. 2010 Jul;17 Suppl 1:15-21. doi: 10.1111/j.1468-1331.2010.03045.x. Review.

PMID:
20590803
9.

Botulinum toxin therapy for blepharospasm in the otolaryngology clinic.

Lassen LF, Adams J.

ORL Head Neck Nurs. 1994 Summer;12(3):12-3.

PMID:
8564763
10.
11.

Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.

Bhidayasiri R, Cardoso F, Truong DD.

Eur J Neurol. 2006 Feb;13 Suppl 1:21-9. Review.

PMID:
16417594
12.

[Botulinum toxin in the treatment of facial dystonia: evaluation of its efficacy and patients' satisfaction along the treatment].

Costa PG, Aoki L, Saraiva FP, Matayoshi S.

Arq Bras Oftalmol. 2005 Jul-Aug;68(4):471-4. Epub 2005 Nov 22. Portuguese.

13.

Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening.

Forget R, Tozlovanu V, Iancu A, Boghen D.

Neurology. 2002 Jun 25;58(12):1843-6.

PMID:
12084888
14.

Botulinum toxin in the treatment of neurological disorders.

Denislic M, Pirtosek Z, Vodusek DB, Zidar J, Meh D.

Ann N Y Acad Sci. 1994 Mar 9;710:76-87.

PMID:
8154763
15.

Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study.

Mezaki T, Kaji R, Kohara N, Fujii H, Katayama M, Shimizu T, Kimura J, Brin MF.

Neurology. 1995 Mar;45(3 Pt 1):506-8.

PMID:
7898706
16.

Complete secondary botulinum toxin therapy failure in blepharospasm.

Dressler D.

J Neurol. 2000 Oct;247(10):809-10. No abstract available.

PMID:
11127541
17.
18.

Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Kenney C, Jankovic J.

J Neural Transm (Vienna). 2008;115(4):585-91. Epub 2007 Jun 11. Review.

PMID:
17558461
19.

Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey.

Cossu G, Mereu A, Deriu M, Melis M, Molari A, Melis G, Minafra L, Pisano T, Cianchetti C, Ortu E, Sau G, Aiello I, Fresu M, Marrosu MG, Contu P.

Mov Disord. 2006 Nov;21(11):2005-8.

PMID:
16960861
20.

Mitochondriopathy, blepharospasm, and treatment with botulinum toxin.

Müller-Vahl KR, Kolbe H, Egensperger R, Dengler R.

Muscle Nerve. 2000 Apr;23(4):647-8. No abstract available.

PMID:
10716779

Supplemental Content

Support Center